• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dynamic Pharmaceuticals Invesco ETF (NY: PJP )

    83.76 -2.05 (-2.39%)
    Official Closing Price Updated: 6:30 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,621
    Open 85.76
    Bid (Size) 82.04 (24)
    Ask (Size) 85.11 (23)
    Prev. Close 85.81
    Today's Range 83.68 - 85.76
    52wk Range 69.34 - 89.87
    Shares Outstanding 32,200
    Dividend Yield 0.96%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
    FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency. 
    Via Benzinga
    Topics Government
    Exposures Political Product Safety
    FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
    The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak. 
    Via Benzinga
    Topics ETFs
    Exposures COVID-19 Product Safety

    Performance

    YTD
    +9.56%
    +9.56%
    1 Month
    -5.17%
    -5.17%
    3 Month
    -1.81%
    -1.81%
    6 Month
    +3.59%
    +3.59%
    1 Year
    +20.29%
    +20.29%

    More News

    Read More
    COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch
    Via Benzinga
    Exposures COVID-19
    Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
    Via Benzinga
    Topics Bankruptcy Lawsuit
    Exposures Financial Legal
    A Look At Pharma ETFs Post Q1 Earnings
    Via Talk Markets
    Topics ETFs
    A Look At Pharma ETFs After Q4 Earnings
    Via Talk Markets
    Topics ETFs
    Government-granted Patent Monopolies Are Not The Free Market
    Via Talk Markets
    Topics Intellectual Property
    Exposures Intellectual Property
    Time For Gilead Sciences-Heavy ETFs?
    Via Talk Markets
    Pharma ETFs in Focus Post Q2 Earnings
    Via Talk Markets
    Topics ETFs
    Want to Invest in Pharmaceutical Stocks but Don't Know How? Try This ETF.
    Via The Motley Fool
    Pharma ETFs Gain Post Q1 Earnings
    Via Talk Markets
    A Look At Pharma ETFs Post Q4 Earnings
    Via Talk Markets
    Pharma ETFs In Focus Post Q3 Earnings
    Via Talk Markets
    Wave of Solid Q3 Earnings Push Pharma ETFs Higher
    Via Talk Markets
    Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
    Via Talk Markets
    Exposures COVID-19 Product Safety
    3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
    Via Talk Markets
    Exposures COVID-19
    3 Cheap Pharmaceutical Stocks to Grab Now
    Via Talk Markets
    Exposures COVID-19
    Pharma ETFs in Focus Post Q1 Earnings
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.